
|Articles|January 17, 2013
Revisiting Transcleral Cyclophotocoagulation
Ike K. Ahmed, MD demonstrates TSCPC with treatment at 1250 mW of power for 4000 ms, with an application of approximately 12 to 15 spots along the limbus with the Iridex G-Probe.
Advertisement
Ike K. Ahmed, MD demonstrates TSCPC with treatment at 1250 mW of power for 4000 ms, with an application of approximately 12 to 15 spots along the limbus with the Iridex G-Probe.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient
2
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
3
Q&A: Advancing a long-acting anti-VEGF candidate: What it means for retinal disease
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5


















































.png)


